Oppenheimer & CO Inc Veru Inc. Transaction History
Oppenheimer & CO Inc
- $7.23 Billion
- Q2 2025
A detailed history of Oppenheimer & CO Inc transactions in Veru Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 1,313,021 shares of VERU stock, worth $4.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,313,021
Previous 1,325,246
0.92%
Holding current value
$4.16 Million
Previous $649,000
17.26%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding VERU
# of Institutions
138Shares Held
43.8MCall Options Held
50.5KPut Options Held
824K-
Black Rock Inc. New York, NY7.65MShares$24.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.41MShares$20.3 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.91MShares$15.6 Million0.56% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.62MShares$8.31 Million0.0% of portfolio
-
Ubs Group Ag1.65MShares$5.25 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $254M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....